Fennec Pharmaceuticals (FENC) Times Interest Earned (2014 - 2025)
Fennec Pharmaceuticals (FENC) posted Times Interest Earned of -$1.07 for Q4 2025, down 231.61% on a QoQ basis from -$0.32 in Q3 2025, and down 10.62% year-over-year from -$1.2 in Q4 2024.
Fennec Pharmaceuticals (FENC) Times Interest Earned (2014 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$1.07 for Q4 2025.
- Quarterly Times Interest Earned fell 10.62% year-over-year to -$1.07 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.51 (down 339.31% YoY) and the FY2025 annual result came in at -$0.14, down 375.4% from the prior year.
- Times Interest Earned was -$1.07 for Q4 2025 at Fennec Pharmaceuticals, down from -$0.32 in the prior quarter.
- Across five years, Times Interest Earned topped out at $13.29 in Q1 2024 and bottomed at -$1230.8 in Q1 2021.
- A 5-year average of -$83.43 and a median of -$5.37 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned plunged 63064.22% — and 2024, when it surged 301.26%.
- Fennec Pharmaceuticals' Times Interest Earned stood at -$67.85 in 2021, then surged by 87.85% to -$8.25 in 2022, then surged by 75.9% to -$1.99 in 2023, then jumped by 51.34% to -$0.97 in 2024, then retreated by 10.62% to -$1.07 in 2025.
- Business Quant data shows FENC's Times Interest Earned at -$1.07 in Q4 2025, -$0.32 in Q3 2025, and -$4.6 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -1.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.07 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -4.60 |
| Mar 31, 2025 | -1.36 |
| Dec 31, 2024 | -0.97 |
| Sep 30, 2024 | -5.08 |
| Jun 30, 2024 | -4.83 |
| Mar 31, 2024 | 13.29 |
| Dec 31, 2023 | -1.99 |
| Sep 30, 2023 | -1.19 |
| Jun 30, 2023 | -5.66 |
| Mar 31, 2023 | -6.60 |
| Dec 31, 2022 | -8.25 |
| Sep 30, 2022 | -45.14 |
| Jun 30, 2022 | -87.88 |
| Mar 31, 2022 | -61.14 |
| Dec 31, 2021 | -67.85 |
| Sep 30, 2021 | -75.87 |
| Jun 30, 2021 | -71.27 |
| Mar 31, 2021 | -1,230.75 |